Paragon 28 News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.11.24	Paragon 28 to Present at the 36th Annual Piper Sandler Healthcare Conference (Businesswire)
17.10.24	Paragon 28 To Report Third Quarter 2024 Financial Results on November 12, 2024 (Businesswire)
16.10.24	Paragon 28 Launches the Phantom® Fibula Nail System for Less Invasive Fracture Repair (Businesswire)
10.09.24	Paragon 28 Introduces a Novel Right-Angle Drill for the APEX 3D™ Total Ankle Replacement System (Businesswire)
04.09.24	Paragon 28 Launches the R3FLEX™ Stabilization System to Anatomically Repair Ankle Syndesmotic Injuries (Businesswire)
17.07.24	Paragon 28 to Report Second Quarter 2024 Financial Results on August 8, 2024 (Businesswire)
08.05.24	Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance (Businesswire)
02.05.24	Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference (Businesswire)
04.04.24	Paragon 28 CFO Stephen Deitsch Resigns; Names Interim Replacement; Backs Annual Revenue Outlook (RTTNews)
04.04.24	Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024 (Businesswire)
28.03.24	Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System (Businesswire)
29.02.24	Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance (Businesswire)
12.02.24	Paragon 28 to Present at the CG 2024 Musculoskeletal Conference (Businesswire)
06.02.24	Paragon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 (Businesswire)
01.02.24	Paragon 28 Launches PRECISION® MIS Bunion System Offering Surgeons a Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions (Businesswire)
30.01.24	Paragon 28 Announces the Launch of the FJ2000™ Power Console and Burr System Designed Specifically for Foot and Ankle Procedures (Businesswire)
26.01.24	Paragon 28 Launches the Mister Tendon™ Harvester System – The First and Only Minimally Invasive Harvesting System for FHL and FDL Tendon Transfer Procedures (Businesswire)
17.01.24	Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures (Businesswire)
08.01.24	Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 (Businesswire)
05.01.24	Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ Tape (Businesswire)
19.12.23	Paragon 28 to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Businesswire)
14.11.23	Paragon 28 Launches BEAST™ Cortical Fibers Expanding its Biologics Portfolio (Businesswire)
14.11.23	Paragon 28 Launches JAWS™ Great White Staple System Further Expanding its Nitinol Staple Offering (Businesswire)
13.11.23	Paragon 28 Adds Second Mobile Medical Education Lab Significantly Expanding Upon Wildly Successful Foot and Ankle Surgeon Training Program (Businesswire)
07.11.23	Paragon 28 Reports Third Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance (Businesswire)
07.11.23	Paragon 28 Announces New $150 Million Credit Facility Replacing Existing $90 Million Credit Facility (Businesswire)
03.11.23	Paragon 28 to Present at Upcoming Investor Conferences (Businesswire)
17.10.23	Paragon 28 To Report Third Quarter Financial Results on November 7, 2023 (Businesswire)
11.09.23	Paragon 28®, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus™ System for use in Conjunction with the APEX 3D™ Total Ankle Replacement System (Businesswire)
28.08.23	Paragon 28 to Present at the Morgan Stanley 21st Annual Global Healthcare Conference (Businesswire)
02.08.23	Paragon 28 Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance (Businesswire)
28.07.23	Paragon 28 to Present at the Canaccord Genuity 43rd Annual Growth Conference (Businesswire)
12.07.23	Paragon 28 To Report Second Quarter Financial Results on August 2, 2023 (Businesswire)
23.05.23	Paragon 28 Launches Comprehensive Supramalleolar Osteotomy System (Businesswire)
04.05.23	Paragon 28 Reports First Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance (Businesswire)
26.04.23	Paragon 28 to Present at the Bank of America Securities 2023 Healthcare Conference (Businesswire)
24.04.23	Paragon 28 Launches Phantom® Metatarsal Shortening System (Businesswire)
20.04.23	Paragon 28 To Report First Quarter Financial Results on May 4, 2023 (Businesswire)
02.03.23	Paragon 28 Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance (Businesswire)
01.03.23	Paragon 28 to Present at Upcoming Investor Conferences (Businesswire)
17.02.23	Paragon 28, Inc. Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock (Businesswire)
16.02.23	Paragon 28 To Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023 (Businesswire)
26.01.23	Paragon 28, Inc. Announces Pricing of Public Offering (Businesswire)
25.01.23	Paragon 28, Inc. Announces Proposed Public Offering of Common Stock (Businesswire)
10.01.23	Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022 (Businesswire)
16.11.22	Paragon 28 to Present at The 34th Annual Piper Sandler Healthcare Conference (Businesswire)
10.11.22	Paragon 28 Reports Third Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance (Businesswire)
27.10.22	Paragon 28 To Report Third Quarter 2022 Financial Results on November 10, 2022 (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	121.15	2.19 %	K V
Logitech Intl	72.20	1.66 %	K V
Lonza Grp	526.60	1.00 %	K V
Swiss Re	129.35	0.82 %	K V
UBS Group	28.35	0.18 %	K V
Givaudan	3’901.00	-0.81 %	K V
Swiss Life Hldg	725.40	-1.12 %	K V
Holcim	89.78	-1.12 %	K V
Novartis	91.93	-1.87 %	K V
Sonova Hldg	306.20	-1.89 %	K V

Nachrichten zu Paragon 28 Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten